A citation-based method for searching scientific literature

H J Wolfe, K E Melvin, S J Cervi-Skinner, A A Saadi, J F Juliar, C E Jackson, A H Tashjian. N Engl J Med 1973
Times Cited: 433

List of co-cited articles
901 articles co-cited >1

Times Cited
  Times     Co-cited

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.
L M Mulligan, J B Kwok, C S Healey, M J Elsdon, C Eng, E Gardner, D R Love, S E Mole, J K Moore, L Papi. Nature 1993

Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.
H Donis-Keller, S Dou, D Chi, K M Carlson, K Toshima, T C Lairmore, J R Howe, J F Moley, P Goodfellow, S A Wells. Hum Mol Genet 1993

Guidelines for diagnosis and therapy of MEN type 1 and type 2.
M L Brandi, R F Gagel, A Angeli, J P Bilezikian, P Beck-Peccoz, C Bordi, B Conte-Devolx, A Falchetti, R G Gheri, A Libroia,[...]. J Clin Endocrinol Metab 2001

Early malignant progression of hereditary medullary thyroid cancer.
Andreas Machens, Patricia Niccoli-Sire, Josef Hoegel, Karin Frank-Raue, Theo J van Vroonhoven, Hans-Dietrich Roeher, Robert A Wahl, Peter Lamesch, Friedhelm Raue, Bernard Conte-Devolx,[...]. N Engl J Med 2003

The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.
C Eng, D Clayton, I Schuffenecker, G Lenoir, G Cote, R F Gagel, H K van Amstel, C J Lips, I Nishisho, S I Takai,[...]. JAMA 1996

Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.
C J Lips, R M Landsvater, J W Höppener, R A Geerdink, G Blijham, J M van Veen, A P van Gils, M J de Wit, R A Zewald, M J Berends. N Engl J Med 1994

A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.
R M Hofstra, R M Landsvater, I Ceccherini, R P Stulp, T Stelwagen, Y Luo, B Pasini, J W Höppener, H K van Amstel, G Romeo. Nature 1994

Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A.
S A Wells, D D Chi, K Toshima, L P Dehner, C M Coffin, S B Dowton, J L Ivanovich, M K DeBenedetti, W G Dilley, J F Moley. Ann Surg 1994

Medullary thyroid cancer: management guidelines of the American Thyroid Association.
Richard T Kloos, Charis Eng, Douglas B Evans, Gary L Francis, Robert F Gagel, Hossein Gharib, Jeffrey F Moley, Furio Pacini, Matthew D Ringel, Martin Schlumberger,[...]. Thyroid 2009

Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine.
E Modigliani, R Cohen, J M Campos, B Conte-Devolx, B Maes, A Boneu, M Schlumberger, J C Bigorgne, P Dumontier, L Leclerc,[...]. Clin Endocrinol (Oxf) 1998

Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity.
J B HAZARD, W A HAWK, G CRILE. J Clin Endocrinol Metab 1959

Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience.
H Dralle, O Gimm, D Simon, K Frank-Raue, G Görtz, B Niederle, R A Wahl, B Koch, S Walgenbach, R Hampel,[...]. World J Surg 1998

Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A.
Michael A Skinner, Jeffrey A Moley, William G Dilley, Kouros Owzar, Mary K Debenedetti, Samuel A Wells. N Engl J Med 2005

The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience.
R F Gagel, A H Tashjian, T Cummings, N Papathanasopoulos, M M Kaplan, R A DeLellis, H J Wolfe, S Reichlin. N Engl J Med 1988

Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B.
K M Carlson, S Dou, D Chi, N Scavarda, K Toshima, C E Jackson, S A Wells, P J Goodfellow, H Donis-Keller. Proc Natl Acad Sci U S A 1994

Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B.
M Santoro, F Carlomagno, A Romano, D P Bottaro, N A Dathan, M Grieco, A Fusco, G Vecchio, B Matoskova, M H Kraus. Science 1995

Early presentation of metastatic medullary carcinoma in multiple endocrine neoplasia, type IIA: implications for therapy.
J R Gill, M Reyes-Múgica, S Iyengar, K K Kidd, R J Touloukian, C Smith, M S Keller, M Genel. J Pediatr 1996

Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship.
Linwah Yip, Gilbert J Cote, Suzanne E Shapiro, Gregory D Ayers, Cynthia E Herzog, Rena V Sellin, Steven I Sherman, Robert F Gagel, Jeffrey E Lee, Douglas B Evans. Arch Surg 2003

C-cell hyperplasia in thyroid tissue adjacent to follicular cell tumors.
J Albores-Saavedra, H Monforte, M Nadji, A R Morales. Hum Pathol 1988

Sex-related C cell hyperplasia in the normal human thyroid: a quantitative autopsy study.
S Guyétant, M C Rousselet, M Durigon, D Chappard, B Franc, O Guerin, J P Saint-André. J Clin Endocrinol Metab 1997

Genotype-phenotype correlations in hereditary medullary thyroid carcinoma: oncological features and biochemical properties.
A Machens, O Gimm, R Hinze, W Höppner, B O Boehm, H Dralle. J Clin Endocrinol Metab 2001

Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.
C Eng, D P Smith, L M Mulligan, M A Nagai, C S Healey, M A Ponder, E Gardner, G F Scheumann, C E Jackson, A Tunnacliffe. Hum Mol Genet 1994

Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma.
H Dralle, I Damm, G F Scheumann, J Kotzerke, E Kupsch, H Geerlings, R Pichlmayr. Surg Today 1994

C cell hyperplasia/neoplasia.
V A LiVolsi. J Clin Endocrinol Metab 1997

Malignant progression from C-cell hyperplasia to medullary thyroid carcinoma in 167 carriers of RET germline mutations.
Andreas Machens, Hans-Jürgen Holzhausen, Phuong Nguyen Thanh, Henning Dralle. Surgery 2003

C-cell hyperplasia and medullary thyroid microcarcinoma.
J A Albores-Saavedra, J E Krueger. Endocr Pathol 2001

Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.
Rossella Elisei, Barbara Cosci, Cristina Romei, Valeria Bottici, Giulia Renzini, Eleonora Molinaro, Laura Agate, Agnese Vivaldi, Pinuccia Faviana, Fulvio Basolo,[...]. J Clin Endocrinol Metab 2008

Early or prophylactic thyroidectomy in MEN 2/FMTC gene carriers: results in 71 thyroidectomized patients. The French Calcitonin Tumours Study Group (GETC).
P Niccoli-Sire, A Murat, E Baudin, J F Henry, C Proye, J C Bigorgne, B Bstandig, E Modigliani, S Morange, M Schlumberger,[...]. Eur J Endocrinol 1999

Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
Gabriela E Sanso, Horacio M Domene, RudazMariaC Garcia, Eduardo Pusiol, MondinoAnaK de, Maria Roque, Alejandro Ring, Hector Perinetti, Boris Elsner, Sonia Iorcansky,[...]. Cancer 2002

Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients.
P Niccoli-Sire, A Murat, V Rohmer, S Franc, G Chabrier, L Baldet, B Maes, F Savagner, S Giraud, S Bezieau,[...]. J Clin Endocrinol Metab 2001

Advances in the management of hereditary medullary thyroid cancer.
A Machens, J Ukkat, M Brauckhoff, O Gimm, H Dralle. J Intern Med 2005

A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10.
C G Mathew, K S Chin, D F Easton, K Thorpe, C Carter, G I Liou, S L Fong, C D Bridges, H Haak, A C Kruseman. Nature 1987

Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Le Groupe d'Etude des Tumeurs a Calcitonine.
I Schuffenecker, N Ginet, D Goldgar, C Eng, B Chambe, A Boneu, C Houdent, D Pallo, M Schlumberger, C Thivolet,[...]. Am J Hum Genet 1997

C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin.
K Kaserer, C Scheuba, N Neuhold, A Weinhäusel, H Vierhapper, O A Haas, B Niederle. Am J Surg Pathol 1998

Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.
M A Skinner, M K DeBenedetti, J F Moley, J A Norton, S A Wells. J Pediatr Surg 1996

Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients.
K Kaserer, C Scheuba, N Neuhold, A Weinhäusel, O A Haas, H Vierhapper, B Niederle. Am J Surg Pathol 2001

Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome: influence of the stage on the clinical course.
S Leboulleux, J P Travagli, B Caillou, A Laplanche, J M Bidart, M Schlumberger, E Baudin. Cancer 2002

Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level.
Andreas Machens, Ulrich Schneyer, Hans-Jürgen Holzhausen, Henning Dralle. J Clin Endocrinol Metab 2005

Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype.
K Frank-Raue, H Buhr, H Dralle, E Klar, N Senninger, T Weber, S Rondot, W Höppner, F Raue. Eur J Endocrinol 2006

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.